BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22078051)

  • 1. [Careful: skins cancers and voriconazole].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
    [No Abstract]   [Full Text] [Related]  

  • 2. Phototoxicity and photocarcinogenesis associated with voriconazole.
    Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
    Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
    Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
    AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
    [No Abstract]   [Full Text] [Related]  

  • 4. Voriconazole-associated phototoxic effects and lentigo formation in an African American man.
    Elbaum DJ; Cowen EW
    Arch Dermatol; 2012 Aug; 148(8):965-6. PubMed ID: 22911208
    [No Abstract]   [Full Text] [Related]  

  • 5. High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
    Rondeau S; Couderc L; Dominique S; Pramil S; Leguillon C; Masseline B; Favennec L; Marguet C
    Eur Respir J; 2012 Mar; 39(3):782-4. PubMed ID: 22379155
    [No Abstract]   [Full Text] [Related]  

  • 6. Bullous phototoxicity from voriconazole.
    Barbosa NS; Wetter DA
    J Emerg Med; 2014 Mar; 46(3):e83-4. PubMed ID: 24412056
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the "therapeutic range" for voriconazole?
    Lewis RE
    Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252
    [No Abstract]   [Full Text] [Related]  

  • 8. Voriconazole-associated phototoxicity.
    Riahi RR; Cohen PR
    Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
    Feist A; Lee R; Osborne S; Lane J; Yung G
    J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
    McCarthy KL; Playford EG; Looke DF; Whitby M
    Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Voriconazole-associated phototoxicity].
    Serra Soler G; Delgado Sánchez O; Esteban Marcos E; Martínez-López I; Femenías Sureda M
    Farm Hosp; 2006; 30(6):386-7. PubMed ID: 17298198
    [No Abstract]   [Full Text] [Related]  

  • 12. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
    Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
    J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
    Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
    J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 15. Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
    Pea F; Viale P
    Ther Drug Monit; 2009 Feb; 31(1):135-6. PubMed ID: 19077926
    [No Abstract]   [Full Text] [Related]  

  • 16. Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
    Askari E; Jarque I; Nicolás Franco S; Cáceres Agra JJ
    Rev Esp Quimioter; 2010 Dec; 23(4):210-2. PubMed ID: 21191561
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of voriconazole and dose individualization.
    Lutsar I; Hodges MR; Tomaszewski K; Troke PF; Wood ND
    Clin Infect Dis; 2003 Apr; 36(8):1087-8. PubMed ID: 12684928
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe phototoxicity associated with long-term voriconazole treatment.
    Vöhringer S; Schrum J; Ott H; Höger PH
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):274-6. PubMed ID: 21050383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
    Hansford JR; Cole C; Blyth CC; Gottardo NG
    J Antimicrob Chemother; 2012 Jul; 67(7):1807-9. PubMed ID: 22454488
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
    Epaulard O; Saint-Raymond C; Villier C; Charles J; Roch N; Beani JC; Leccia MT
    Clin Microbiol Infect; 2010 Sep; 16(9):1362-4. PubMed ID: 19930272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.